Pharmacopeia beats EPS estimates

PCOP reported fourth quarter and fiscal year the EPS of $0.38 and $0.70, beating EPS consensus by $0.08 and $0.06, respectively. The results were driven by a 22 percent increase in revenue to $119 mil...